Selank and the stress axis: a well-described system and a thin literature

Selank is described almost everywhere as a stress-response compound acting on the HPA axis. The claim is repeated so consistently that it reads as settled. It is not, and the quickest way to see why is to look at what the published work actually measured.

Before any of that: Selank is a registered medicine in Russia, developed at the Institute of Molecular Genetics in Moscow, and approved nowhere else. Not Health Canada, not the FDA, not the EMA. The Russian clinical literature is in the anxiety category and is largely untranslated. Everything below sits inside that frame.

The system the claim refers to

The hypothalamic-pituitary-adrenal axis is the body's central stress circuit, and it is one of the better-mapped cascades in physiology:

1. A stressor is registered in the hypothalamus, which releases corticotropin-releasing hormone.
2. CRH drives the anterior pituitary to release adrenocorticotropic hormone.
3. ACTH drives the adrenal cortex to release cortisol and other glucocorticoids.
4. Cortisol mobilises energy, modulates immune function and alters behaviour.
5. Cortisol also feeds back onto the hypothalamus and pituitary, which is what normally shuts the loop down.

A compound said to act on this axis is being located somewhere specific in that chain. The test of the claim is a measurement: CRH, ACTH, cortisol or corticosterone, basal or in response to a stressor. That is a routine assay, and it is not expensive.

What the cited literature measured

Four papers carry this article. None of them measured cortisol or corticosterone, and none of them measured ACTH.

GABAergic gene expression. Volkova and colleagues reported that Selank administration affects the expression of some genes involved in GABAergic neurotransmission (PMID 26924987). This is the closest thing in the reference list to a stress mechanism, and it is the only one published in a Western journal, in Frontiers in Pharmacology. GABA is the brain's principal inhibitory transmitter and inhibitory tone is part of how stress responses are contained, so the finding is relevant. What it is not is an HPA measurement.

The mechanistic distinction matters for a second reason. Benzodiazepines act by potentiating the GABA-A receptor directly — they bind it. Volkova's result is about transcript levels of genes in the GABAergic system, which is a different kind of effect at a different point in the chain. Selank is often compared to benzodiazepines; the comparison is reasonable as a research design choice and misleading as a statement of mechanism.

Hippocampal BDNF. Inozemtseva and colleagues reported that Selank regulates BDNF expression in rat hippocampus in vivo, intranasally administered (PMID 18841804). The hippocampus is dense in glucocorticoid receptors and is one of the structures chronic stress is known to affect, so this connects to stress biology — but again by inference, through a neurotrophin, not through a hormone measurement. The learning side of that paper is discussed in Selank for Cognitive Performance Research.

Behavioural learning. Kozlovskii and Danchev on conditioned active avoidance in rats (PMID 14552529), and Sollertinskaya and Shorokhov on forms of learning in lower monkeys. Avoidance learning uses an aversive stimulus, so it is adjacent to stress research, but its endpoints are behavioural acquisition and performance.

So: a transcriptional result in the GABAergic system, a neurotrophin result in hippocampus, and two behavioural learning papers. The HPA axis is the frame everyone puts around this, and nothing in it is an HPA result.

The tuftsin origin, and why it is interesting anyway

Selank is a synthetic analogue of tuftsin, a tetrapeptide cleaved from immunoglobulin G with documented effects on immune cell function. The analogue adds a Pro-Gly-Pro tail for stability, giving Thr-Lys-Pro-Arg-Pro-Gly-Pro.

That lineage is the genuinely unusual thing about the compound, and it is unusual in a way that bears on stress. Sustained HPA activation produces immune consequences — this is well established independently of any peptide. A molecule derived from an immunopeptide and studied for anxiety sits across both sides of that relationship, which makes it an interesting tool for asking how the two connect.

Interesting is not the same as established. The stress-immune thread for Selank specifically is an inference from its chemical origin, not a published finding in the material cited here. Write it down as a reason to look, not as a result.

Where the evidence stops

Two structural weaknesses run through all of it. The literature comes overwhelmingly from one research tradition, which means consistency across papers partly reflects shared methods and assumptions rather than independent confirmation. And the strongest claims — the clinical ones — are the ones a reader outside Russia can least easily check.

What this means for a research question

If a question is about GABAergic transcript levels or hippocampal BDNF, there is a published result to extend. If it is about cortisol dynamics, restraint or social-defeat paradigms, or stress-induced immune change, the Selank literature does not yet contain that experiment — which makes it an open question rather than a replication, and a protocol should be designed accordingly.

For the learning and memory thread, see Selank for Cognitive Performance Research. The other peptide from the same Moscow laboratory, built on the same stabilising tail, is Semax, whose literature is organised around ischaemia rather than anxiety. Nothing here is medical, dosing, or therapeutic guidance.

Selank is supplied here as Selank, and is reconstituted with bacteriostatic water. Janoshik-verified by HPLC with mass-spec identity confirmation; 100% synthetic. The measured purity for each lot is stated on its product page. For laboratory research use only.

Common questions

Does Selank lower cortisol? No paper in the reference list below measured cortisol or corticosterone. Anyone stating that it does should be asked for the citation.

Why is it called a stress compound then? Because its Russian clinical use is in the anxiety category, and because its published mechanisms — inhibitory signalling and a hippocampal neurotrophin — are plausibly stress-relevant. Plausibility and measurement are different things, and the gap between them is this article's whole subject.

How does its mechanism differ from a benzodiazepine? A benzodiazepine binds and potentiates the GABA-A receptor. The published Selank result is a change in expression of genes in the GABAergic system (PMID 26924987), which is upstream and indirect. Treating the two as the same mechanism with different labels is an error.

Is any of this human evidence? The mechanism papers are rodent. Human data exists in Russian clinical research on anxiety, concentrated in one country, poorly replicated, and not reviewed by Health Canada, the FDA or the EMA. Material sold here is a research chemical.

Selected Research References

1. Kozlovskii II, Danchev ND. The Optimizing Effect of the Synthetic Peptide Selank on a Conditioned Active Avoidance Reflex in Rats. Neuroscience and Behavioral Physiology. 2003;33(7):639-643. pubmed.ncbi.nlm.nih.gov/14552529
2. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. 2016;7:31. pubmed.ncbi.nlm.nih.gov/26924987
3. Inozemtseva LS, Karpenko EA, Dolotov OV, et al. Intranasal Administration of the Peptide Selank Regulates BDNF Expression in the Rat Hippocampus In Vivo. Doklady Biological Sciences. 2008;421:241-243. pubmed.ncbi.nlm.nih.gov/18841804
4. Sollertinskaya TN, Shorokhov MV. Comparative Characteristics of the Effects of Selank and Tactivin on Selective and Generalized Forms of Learning in Lower Monkeys. Zhurnal Vysshei Nervnoi Deiatel'nosti Imeni I P Pavlova. 2010. (Reference on Selank stress-cognition interaction research.)

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.